A detailed history of Halpern Financial, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Halpern Financial, Inc. holds 50 shares of NVO stock, worth $5,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 213 76.53%
Holding current value
$5,381
Previous $30.4 Million 80.84%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$119.07 - $145.42 $19,408 - $23,703
-163 Reduced 76.53%
50 $5.82 Million
Q2 2024

Jul 08, 2024

BUY
$122.71 - $146.91 $13,866 - $16,600
113 Added 113.0%
213 $30.4 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $4,547 - $9,977
50 Added 100.0%
100 $9.09 Million
Q4 2022

Sep 21, 2023

BUY
$102.55 - $135.33 $5,127 - $6,766
50 New
50 $6.77 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Halpern Financial, Inc. Portfolio

Follow Halpern Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halpern Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Halpern Financial, Inc. with notifications on news.